Browsing by Yonsei Author : Lee, Yong Ho

eperson profile image
Name:
Lee, Yong Ho [이용호]
orcid http://orcid.org/0000-0002-6219-4942
Department :
College of Medicine (의과대학) - Dept. of Internal Medicine (내과학교실)
Scopus ID :
Scopus (56424219700)

Keyword Cloud

Researcher Network

Showing results 1 to 50 of 221

This table browses all dspace content
Issue DateTitleJournal Title
2023Non-Alcoholic Fatty Liver Disease with Sarcopenia and Carotid Plaque Progression Risk in Patients with Type 2 Diabetes Mellitus DIABETES & METABOLISM JOURNAL
2023Moderate-intensity statin with ezetimibe vs. high-intensity statin in patients with diabetes and atherosclerotic cardiovascular disease in the RACING trialEUROPEAN HEART JOURNAL
2023Prognostic value of resting heart rate in predicting undiagnosed diabetes in adults: Korean National Health and Nutrition Examination Survey 2008–2018 NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
2022Effect of low skeletal muscle mass and sarcopenic obesity on chronic kidney disease in patients with type 2 diabetesOBESITY
2022Adherence to healthy lifestyle behaviors as a preventable risk factor for severe hypoglycemia in people with type 2 diabetes: A longitudinal nationwide cohort study JOURNAL OF DIABETES INVESTIGATION
2022Effect of Dapagliflozin in Combination with Lobeglitazone and Metformin in Korean Patients with Type 2 Diabetes in Real-World Clinical Practice YONSEI MEDICAL JOURNAL
2022Editorial: Pharmacology and treatment methods for NAFLD in the context of diabetes FRONTIERS IN ENDOCRINOLOGY
2022Fibrotic Burden Determines Cardiovascular Risk among Subjects with Metabolic Dysfunction-Associated Fatty Liver Disease GUT AND LIVER
2022Dapagliflozin attenuates diabetes-induced diastolic dysfunction and cardiac fibrosis by regulating SGK1 signaling BMC MEDICINE
2022The effects of the voglibose on non-alcoholic fatty liver disease in mice model SCIENTIFIC REPORTS
2022Protective Effect of Delta-Like 1 Homolog Against Muscular Atrophy in a Mouse Model Endocrinology and Metabolism(대한내분비학회지)
2022Effects of a Phosphodiesterase inhibitor on the Browning of Adipose Tissue in Mice BIOMEDICINES
2022Advanced Liver Fibrosis Is Associated with Chronic Kidney Disease in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease DIABETES & METABOLISM JOURNAL
2022Differences in complication patterns in subgroups of type 2 diabetes according to insulin resistance and beta-cell function SCIENTIFIC REPORTS
2022A GLP-1/GLP-2 receptor dual agonist to treat NASH: Targeting the gut-liver axis and microbiomeHEPATOLOGY
2022Sodium Glucose Cotransporter-2 Inhibitors as an Add-on Therapy to Metformin Plus Dipeptidyl Peptidase-4 Inhibitor in Patients with Type 2 Diabetes YONSEI MEDICAL JOURNAL
2022Efficacy and Safety of a New Sustained-release Pregabalin Formulation Compared With Immediate-release Pregabalin in Patients With Peripheral Neuropathic Pain: A Randomized Noninferiority Phase 3 Trial CLINICAL JOURNAL OF PAIN
2022Association of Metabolomic Change and Treatment Response in Patients with Non-Alcoholic Fatty Liver Disease BIOMEDICINES
2022The predicting value of resting heart rate to identify undiagnosed diabetes in Korean adult: Korea National Health and Nutrition Examination Survey EPIDEMIOLOGY AND HEALTH
2022Inhibition of CXXC5 function reverses obesity-related metabolic diseases CLINICAL AND TRANSLATIONAL MEDICINE
2022Short Term Isocaloric Ketogenic Diet Modulates NLRP3 Inflammasome Via B-hydroxybutyrate and Fibroblast Growth Factor 21 FRONTIERS IN IMMUNOLOGY
2022Severe Hypoglycemia Increases Dementia Risk and Related Mortality: A Nationwide, Population-based Cohort StudyJOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
2022Ideal cardiovascular health duration and risk of chronic kidney disease and cardiovascular diseaseHEART
2022Performance of Diabetes and Kidney Disease Screening Scores in Contemporary United States and Korean Populations DIABETES & METABOLISM JOURNAL
2022Ezetimibe combination therapy with statin for non-alcoholic fatty liver disease: an open-label randomized controlled trial (ESSENTIAL study) BMC MEDICINE
2022Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease GUT AND LIVER
2022State-of-the-Art Overview of the Pharmacological Treatment of Non-Alcoholic Steatohepatitis Endocrinology and Metabolism(대한내분비학회지)
2022Analysis of Severe Hypoglycemia Among Adults With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease JAMA NETWORK OPEN
2022Renal Tubular Damage Marker, Urinary N-acetyl-β-D-Glucosaminidase, as a Predictive Marker of Hepatic Fibrosis in Type 2 Diabetes Mellitus DIABETES & METABOLISM JOURNAL
2022Blood Pressure Levels and Risks of Dementia: a Nationwide Study of 4.5 Million PeopleHYPERTENSION
2021The Leg Fat to Total Fat Ratio Is Associated with Lower Risks of Non-Alcoholic Fatty Liver Disease and Less Severe Hepatic Fibrosis: Results from Nationwide Surveys (KNHANES 2008–2011) Endocrinology and Metabolism(대한내분비학회지)
2021Uric Acid Variability as a Predictive Marker of Newly Developed Cardiovascular Events in Type 2 Diabetes FRONTIERS IN CARDIOVASCULAR MEDICINE
2021Proteinuria as a significant predictive factor for the progression of carotid artery atherosclerosis in non-albuminuric type 2 diabetesDIABETES RESEARCH AND CLINICAL PRACTICE
2021Ipragliflozin, an SGLT2 Inhibitor, Ameliorates High-Fat Diet-Induced Metabolic Changes by Upregulating Energy Expenditure through Activation of the AMPK/ SIRT1 Pathway DIABETES & METABOLISM JOURNAL
2021Real-world evidence on the strategy of olmesartan-based triple single-pill combination in Korean hypertensive patients: a prospective, multicenter, observational study (RESOLVE-PRO) Clinical Hypertension
2021Association of circulating metabolites with incident type 2 diabetes in an obese population from a national cohortDIABETES RESEARCH AND CLINICAL PRACTICE
2021Metabolic Dysfunction-Associated Fatty Liver Disease and Incident Cardiovascular Disease Risk: A Nationwide Cohort StudyCLINICAL GASTROENTEROLOGY AND HEPATOLOGY
2021Body Weight Variability: A Marker for Increased Risk or a Causative Factor for Dementia? JOURNAL OF OBESITY & METABOLIC SYNDROME
2021Role of DPP-4 and SGLT2 Inhibitors Connected to Alzheimer Disease in Type 2 Diabetes Mellitus FRONTIERS IN NEUROSCIENCE
2021Non-Laboratory-Based Simple Screening Model for Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Developed Using Multi-Center Cohorts Endocrinology and Metabolism(대한내분비학회지)
2021Association between the severity of liver fibrosis and cardiovascular outcomes in patients with type 2 diabetesJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
2021Risks and Prognoses of Alzheimer's Disease and Vascular Dementia in Patients With Insomnia: A Nationwide Population-Based Study FRONTIERS IN NEUROLOGY
2021Nonalcoholic fatty liver disease, diastolic dysfunction, and impaired myocardial glucose uptake in patients with type 2 diabetesDIABETES OBESITY & METABOLISM
2021Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)AUTOPHAGY
2021O- Linked N-Acetylglucosamine Modification of Mitochondrial Antiviral Signaling Protein Regulates Antiviral Signaling by Modulating Its Activity FRONTIERS IN IMMUNOLOGY
2021Glycaemic control with add-on thiazolidinedione or a sodium-glucose co-transporter-2 inhibitor in patients with type 2 diabetes after the failure of an oral triple antidiabetic regimen: A 24-week, randomized controlled trialDIABETES OBESITY & METABOLISM
2020Metformin and Gastrointestinal Cancer Development in Newly Diagnosed Type 2 Diabetes: A Population-Based Study in Korea CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY
2020Association between liver fibrosis and appendicular skeletal muscle mass during antiviral therapy in chronic hepatitis BDIGESTIVE AND LIVER DISEASE
2020Effect of Switching from Linagliptin to Teneligliptin Dipeptidyl Peptidase-4 Inhibitors in Older Patients with Type 2 Diabetes Mellitus DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY
2020SQSTM1/p62 activates NFE2L2/NRF2 via ULK1-mediated autophagic KEAP1 degradation and protects mouse liver from lipotoxicityAUTOPHAGY

Browse

Links